Investors advised against buying drug stocks like Eli Lilly and Company (LLY) during Fed rate cuts, says Jim Cramer. LLY, with a market cap of $724 billion, developed a weight loss and diabetes wonder drug. The company recently unveiled an AI platform to enhance drug discovery across various medical fields. While LLY shows potential, other AI stocks may offer greater upside and less downside risk.

Read more at Yahoo Finance: Jim Cramer Explains Why Eli Lilly May Not Be Next to Hit $1 Trillion